Wird geladen...
Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer
Non-small-cell lung cancer (NSCLC), a main subtype of lung cancer, is one of the most common causes of cancer death in men and women worldwide. Circulating tumor DNA (ctDNA), tyrosine kinase inhibitors (TKIs) and immunotherapy have revolutionized both our understanding of NSCLC, from its diagnosis t...
Gespeichert in:
| Veröffentlicht in: | Transl Lung Cancer Res |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AME Publishing Company
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7082279/ https://ncbi.nlm.nih.gov/pubmed/32206559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2020.01.09 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|